Back
RXRX
RECURSION PHARMACEUTICALS-A
🇺🇸 NYSE/NASDAQ
👑 Overview
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
-19.52%
Annual Growth
4 years average annual capital growth
🌏
17
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology and chemistry to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components as iterative loops of atoms and bits, scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate silico hypotheses into validated insights and novel chemistry. Its clinical programs in oncology and rare diseases include REC-617, REC-1245, REC-3565 and REC-4539. Its REC-617 is an orally bioavailable, cyclin-dependent kinase 7 (CDK7) inhibitor for the treatment of advanced solid tumors. Its REV102 program targets ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), an enzyme implicated in the pathogenesis of HPP.
📈 Performance
Price History*
-82.80%
1M
1Y
All Time
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$5.28
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in RXRX
17
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
14 weeks
💵 Average investment amount
$1,577
⏰ Last time a customer invested in RXRX
2 days
RXRX investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
28%
50k - 100k
44%
Less than 50k
22%
👶 Age of investors
18 - 25
26 - 34
24%
35 - 90
71%
🙋 Legal gender of investors
Female
59%
Male
41%
Pearlers who invest in RXRX also invest in...
🙌 Performance (5Yr p.a)
294.79%
📊 Share price
$164.92 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
27.10%
📊 Share price
$503.32 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
32.40%
📊 Share price
$146.42 USD
📈 HIGH PRICE GROWTH
Want more shares? Try these...
